Metabolic modulation of the right ventricle and pulmonary circulation in pulmonary arterial hypertension: an interventional study using a Glucagon-like-peptide-1 (GLP-1) agonist
C. Samaranayake (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), J. Pinguel (London, United Kingdom), E. Morris (London, United Kingdom), E. Moriarty (London, United Kingdom), M. Gummadi (London, United Kingdom), K. Dimopoulos (London, United Kingdom), S. Wort (London, United Kingdom), L. Zhao (London, United Kingdom), C. Mccabe (London, United Kingdom)
Source: International Congress 2022 – Novelties in pulmonary hypertension management
Session: Novelties in pulmonary hypertension management
Session type: Oral Presentation
Number: 2275
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Samaranayake (London, United Kingdom), A. Kempny (London, United Kingdom), L. Price (London, United Kingdom), J. Pinguel (London, United Kingdom), E. Morris (London, United Kingdom), E. Moriarty (London, United Kingdom), M. Gummadi (London, United Kingdom), K. Dimopoulos (London, United Kingdom), S. Wort (London, United Kingdom), L. Zhao (London, United Kingdom), C. Mccabe (London, United Kingdom). Metabolic modulation of the right ventricle and pulmonary circulation in pulmonary arterial hypertension: an interventional study using a Glucagon-like-peptide-1 (GLP-1) agonist. 2275
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|